灵康药业
(603669)
| 流通市值：32.53亿 | | | 总市值：32.53亿 |
| 流通股本：7.21亿 | | | 总股本：7.21亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 123,225,366.34 | 323,670,765.11 | 296,100,557.45 | 343,418,554.46 |
| 应收票据及应收账款 | 60,917,763.91 | 80,389,653.46 | 55,561,661.7 | 64,710,631.77 |
| 应收账款 | 60,917,763.91 | 80,389,653.46 | 55,561,661.7 | 64,710,631.77 |
| 应收款项融资 | - | 898,080 | - | 894,240 |
| 预付款项 | 15,249,167.71 | 7,268,295.47 | 7,862,960.7 | 5,678,693.9 |
| 其他应收款合计 | 10,081,012.97 | 5,258,687.48 | 8,242,811.6 | 2,178,554.22 |
| 存货 | 61,483,050.15 | 37,525,751.84 | 58,465,779.3 | 56,768,282.16 |
| 其他流动资产 | 14,950,463.35 | 14,708,653.97 | 15,866,194.04 | 17,293,965.41 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 495,170,740.5 | 725,113,933.72 | 746,729,106.24 | 881,533,254.03 |
| 非流动资产: | | | | |
| 长期股权投资 | 28,760,795.15 | 32,848,981.5 | 37,392,314.09 | 40,874,881.63 |
| 其他权益工具投资 | 60,000,000 | 60,000,000 | 60,000,000 | 60,000,000 |
| 投资性房地产 | 8,028,544.84 | 15,827,614.18 | 16,194,714.63 | 6,606,365.29 |
| 固定资产 | 249,064,032.88 | 248,849,724.18 | 259,754,505.22 | 275,357,994.03 |
| 在建工程 | 231,777,658.08 | 231,519,859.91 | 226,313,215.9 | 220,058,384.57 |
| 使用权资产 | 7,596,099.45 | 8,061,166.77 | 9,229,257.13 | 9,928,665.46 |
| 无形资产 | 104,683,545.22 | 104,852,362.83 | 106,624,944.69 | 108,435,835.2 |
| 长期待摊费用 | 14,820,324.05 | 15,571,390.1 | 16,376,046.01 | 17,147,244.75 |
| 递延所得税资产 | 2,549,079.56 | 2,643,318.26 | 2,191,247.9 | 2,198,900.92 |
| 其他非流动资产 | 3,201,100 | 2,784,425 | 2,359,825 | 2,418,600 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 710,481,179.23 | 722,958,842.73 | 736,436,070.57 | 743,026,871.85 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,205,651,919.73 | 1,448,072,776.45 | 1,483,165,176.81 | 1,624,560,125.88 |
| 流动负债: | | | | |
| 短期借款 | - | 17,359,971.21 | 17,360,718.34 | 117,411,134.98 |
| 应付票据及应付账款 | 61,336,478.54 | 51,829,026.43 | 72,439,516.49 | 95,290,443.47 |
| 其中：应付票据 | 6,715,515.2 | 8,978,661.2 | 20,484,647.05 | 39,876,263.43 |
| 应付账款 | 54,620,963.34 | 42,850,365.23 | 51,954,869.44 | 55,414,180.04 |
| 预收款项 | 552,798.17 | 252,147.56 | 282,329.1 | 169,002.37 |
| 合同负债 | 7,620,462.77 | 9,763,280.66 | 8,044,539.71 | 10,310,811.79 |
| 应付职工薪酬 | 2,999,705.74 | 3,012,105.93 | 3,153,600.29 | 8,756,413.27 |
| 应交税费 | 1,263,383.46 | 1,190,093.41 | 1,025,346.5 | 2,287,091.7 |
| 其他应付款合计 | 5,092,013.41 | 4,683,411.84 | 3,969,895.34 | 3,216,968.51 |
| 一年内到期的非流动负债 | 7,005,670.17 | 5,569,400.99 | 2,837,532.4 | 3,015,839.04 |
| 其他流动负债 | 1,861,638.03 | 2,160,306.36 | 2,056,003.31 | 2,652,739.97 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 87,732,150.29 | 95,819,744.39 | 111,169,481.48 | 243,110,445.1 |
| 非流动负债: | | | | |
| 应付债券 | 251,975,356.88 | 452,851,099.79 | 447,815,132.34 | 439,342,300.23 |
| 租赁负债 | 5,843,096.39 | 5,843,096.39 | 5,843,096.39 | 5,843,096.39 |
| 递延收益 | 2,480,589.41 | 2,550,495.32 | 2,722,364.56 | 2,804,035.47 |
| 递延所得税负债 | 1,898,394.72 | 2,015,291.69 | 2,266,683.22 | 2,418,101.2 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 262,197,437.4 | 463,259,983.19 | 458,647,276.51 | 450,407,533.29 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 349,929,587.69 | 559,079,727.58 | 569,816,757.99 | 693,517,978.39 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 721,240,880 | 721,239,005 | 721,238,653 | 721,238,653 |
| 其他权益工具 | 60,486,347.92 | 94,090,676.22 | 94,091,292.74 | 94,091,292.74 |
| 资本公积 | 262,463,836.51 | 255,642,400.72 | 255,639,079.79 | 255,639,079.79 |
| 减:库存股 | 110,019,565.79 | 110,019,565.79 | 110,019,822.2 | 108,367,599.67 |
| 盈余公积 | 144,362,187.9 | 144,362,187.9 | 144,362,187.9 | 144,362,187.9 |
| 未分配利润 | -222,811,354.5 | -216,321,655.18 | -191,962,972.41 | -175,921,466.27 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 855,722,332.04 | 888,993,048.87 | 913,348,418.82 | 931,042,147.49 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 855,722,332.04 | 888,993,048.87 | 913,348,418.82 | 931,042,147.49 |
| 负债和股东权益合计 | 1,205,651,919.73 | 1,448,072,776.45 | 1,483,165,176.81 | 1,624,560,125.88 |
| 公告日期 | 2024-10-31 | 2024-08-24 | 2024-04-20 | 2024-04-20 |
| 审计意见(境内) | | | | 标准无保留意见 |